This Friday, about 60 patients, mostly women, waited outside the clinic by mid-afternoon, many punctuating the corridor with ...

This Friday, about 60 patients, mostly women, waited outside the clinic by mid-afternoon, many punctuating the corridor with ...

At a national conference in Patna, specialists highlighted a troubling trend: women are increasingly suffering from COPD. The ...

Significant unmet needs among people with RA-ILD have been identified in a recent survey, with clear gaps in the services ...

A meta-analysis identifies immunosuppression and chronic kidney disease as carrying the highest risk for invasive ...

The city has seen a dramatic increase in cases of respiratory infections with the onset of winter, health experts shared, ...

Arquitos Capital Management, an investment management firm, released its third-quarter 2025 investor letter. A copy of the ...

The 2025 ERS Congress highlighted the emerging challenges and innovations reshaping respiratory medicine, as Ravijyot Saggu ...

Nerandomilast is an oral, preferential PDE4B inhibitor approved in China for the treatment of adult patients with IPF and PPF. It was also approved by the U.S. Food and Drug Administration (FDA) for ...

When Amy was first diagnosed with scleroderma, she never imagined it would lead to a lifelong journey with lung disease.

Instead of big incisions, doctors at Jefferson Einstein Hospital are using tiny scopes with tips that freeze. For patients, ...

The U.K. company presented findings that its 360 e-Lung technology could potentially speed up the diagnosis of progressive pulmonary fibrosis by nearly two years in more than half of the patients ...